Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (6990.HK) announced that it will present results from six Kelun-led clinical studies at the 2025 American Society of Clinical Oncology (ASCO) Annual ...

CytoAgents Inc., a clinical-stage biotechnology company developing CTO1681 for the prevention and treatment for Cytokine Release Syndrome (CRS), announced the successful completion of the first dose, ...

Two former FDA leaders look at Commissioner Marty Makary’s early stumbles — and lay out a list of priorities to protect both ...

With its patented, AI-powered, FDA-certified transmission X-ray technology, since 2007 NanoRay Biotech is radically transforming medical and industrial X-ray applications in Taiwan and aims to further ...

Long a lobbying powerhouse in Washington, pharma’s struggling to settle on a strategy for defending itself, according to six industry lobbyists and three company officials who spoke to POLITICO. All ...

("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic medical products and related medical devices, announced today that on April 22, 2025, its subsidiary, Shineco Life ...

Leadgene develops cutting-edge technologies and high-quality biological raw materials reagents. Its recent achievements and ...

The role of insects in drug discovery is expanding, with biopharmaceuticals derived from insect cells offering sustainable ...

Equity markets have been seesawing for the past two weeks. Stocks fell hard after President Donald Trump announced his tariff plans, then bounced back big once he said he would pause expanded tariffs ...

Sylvie Grégoire, Chair of Abivax Board of Directors, commented: “We are delighted to welcome Dominik to the Board at such a pivotal moment for Abivax. His extensive background in global medical ...

Medical equipment maker Thermo Fisher Scientific on Wednesday cut its annual profit forecast, in anticipation of a potential ...

China’s dominance of the market for "active pharmaceutical ingredients" — critical components of drugs — has given it ...